The Role of Skin Biopsy in the Management of Immune Checkpoint Inhibitor Toxicity

被引：0
|
作者：
Cohen, Philip R. [1 ,2 ]
机构：
[1] Univ Calif Sacramento, Davis Med Ctr, Dept Dermatol, Sacramento, CA 95819 USA
[2] Touro Univ Calif, Coll Osteopath Med, Vallejo, CA USA
来源：
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2022年 / 20卷 / 10期
关键词：
D O I：
10.6004/jnccn.2022.7062
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [31] Management of Immune Checkpoint Inhibitor Mediated Myocarditis
    Mudra, Sarah
    Culver, Austin
    Kumar, Ashwin
    Yesilyaprak, Abdullah
    Agrawal, Ankit
    Dey, Amit K.
    Rizk, Alexander
    Li, Jason
    Johnson, Adam
    McGowan, Kevin
    Majid, Muhammad
    Njus, Meredith
    Lawrence, Luke
    Klein, Allan L.
    CIRCULATION, 2023, 148
  • [32] Immunity and immune toxicity: clinical management of immune checkpoint inhibition
    Keilholz, U.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 21 - 21
  • [33] Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review
    Sise, Meghan E.
    Seethapathy, Harish
    Reynolds, Kerry L.
    ONCOLOGIST, 2019, 24 (06): : 735 - 742
  • [34] Management of infliximab-refractory immune checkpoint inhibitor gastrointestinal toxicity: A multicenter case series
    Harvey, Catriona
    Nahar, Kazi Jannatun
    Lo, Serigne N.
    Ahmed, Tasnia
    Farag, Sheima
    Yousaf, Nadia
    Young, Kate
    Tas, Liselotte
    Meerveld-Eggink, Aafke
    Blank, Christian U.
    Thomas, Austin
    McQuade, Jennifer Leigh
    Schilling, Bastian
    Johnson, Douglas Buckner
    Huertas, Roberto Martin
    Arance, Ana Maria
    Lee, Joanna
    Zimmer, Lisa
    Long, Georgina V.
    Menzies, Alexander M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [35] GRAVE CONSEQUENCES OF IMMUNE CHECKPOINT INHIBITOR TOXICITY BEYOND MYOCARDITIS
    Trivedi, Rishi
    Tacon, Phillip
    Aiken, Achilles V.
    Chyu, Kuang-Yuh
    Ebinger, Joseph
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 3470 - 3470
  • [36] Immune Checkpoint Inhibitor Toxicity Review for the Palliative Care Clinician
    Hansen, Eric D.
    Wang, Xiao
    Case, Amy A.
    Puzanov, Igor
    Smith, Tom
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2018, 56 (03) : 460 - 472
  • [37] Immune checkpoint inhibitor and encephalic radiotherapy: Toxicity and Adverse events
    Matteucci, P.
    Santo, B.
    Ippolito, E.
    Zuccoli, P.
    Petrianni, G. M.
    Trecca, P.
    Gentile, S.
    Miele, M.
    Palizzi, S.
    Trodella, L.
    D'Angelillo, R. M.
    Ramella, S.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S678 - S678
  • [38] Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities
    Goodman, Rachel S.
    Jung, Seungyeon
    Balko, Justin M.
    Johnson, Douglas B.
    IMMUNOLOGICAL REVIEWS, 2023, 318 (01) : 157 - 166
  • [39] Predicting and Preventing Immune Checkpoint Inhibitor Toxicity: Targeting Cytokines
    Kang, Jee Hye
    Bluestone, Jeffrey A.
    Young, Arabella
    TRENDS IN IMMUNOLOGY, 2021, 42 (04) : 293 - 311
  • [40] Immune checkpoint inhibitor toxicity in the clinical practice setting.
    Schmidt, Laura
    McGuire, Brian
    Hui, Wendy
    Carro, George W.
    Hensing, Thomas A.
    Shevrin, Daniel H.
    Campbell, Nicholas Paul
    Hanson, Britt Erika
    Brockstein, Bruce
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345